GFER

Chr 16AR

growth factor, augmenter of liver regeneration

Also known as: ALR, ERV1, HERV1, HPO, HPO1, HPO2, HSS, MMCHD

The hepatotrophic factor designated augmenter of liver regeneration (ALR) is thought to be one of the factors responsible for the extraordinary regenerative capacity of mammalian liver. It has also been called hepatic regenerative stimulation substance (HSS). The gene resides on chromosome 16 in the interval containing the locus for polycystic kidney disease (PKD1). The putative gene product is 42% similar to the scERV1 protein of yeast. The yeast scERV1 gene had been found to be essential for oxidative phosphorylation, the maintenance of mitochondrial genomes, and the cell division cycle. The human gene is both the structural and functional homolog of the yeast scERV1 gene. [provided by RefSeq, Jul 2008]

OMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 1.651 OMIM phenotype
Clinical SummaryGFER
🧬
Gene-Disease Validity (ClinGen)
mitochondrial disease · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
9 unique Pathogenic / Likely Pathogenic· 75 VUS of 185 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.65LOEUF
pLI 0.000
Z-score 0.30
OE 0.87 (0.481.65)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.20Z-score
OE missense 1.05 (0.901.23)
114 obs / 108.3 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.87 (0.481.65)
00.351.4
Missense OE?1.05 (0.901.23)
00.61.4
Synonymous OE?1.06
01.21.6
LoF obs/exp: 6 / 6.9Missense obs/exp: 114 / 108.3Syn Z: -0.33
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
moderateGFER-related mitochondrial progressive myopathy with congenital cataract, hearing loss and developmental delayLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6743th %ile
GOF
0.5857th %ile
LOF
0.3261th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

185 submitted variants in ClinVar

Classification Summary

Pathogenic4
Likely Pathogenic5
VUS75
Likely Benign75
Benign15
Conflicting9
4
Pathogenic
5
Likely Pathogenic
75
VUS
75
Likely Benign
15
Benign
9
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
2
0
0
4
Likely Pathogenic
2
2
1
0
5
VUS
4
70
1
0
75
Likely Benign
1
3
21
50
75
Benign
0
1
11
3
15
Conflicting
9
Total9783453183

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

45 pathogenic / likely-pathogenic (of 62) ClinVar copy-number / structural variants overlap GFER — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

GFER · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →